Related references
Note: Only part of the references are listed.The association of phosphodiesterase-5 inhibitors with the biochemical recurrence-free and overall survival of patients with prostate cancer following radical prostatectomy
Kelsey T. Danley et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2022)
Tadalafil enhances the therapeutic efficacy of BET inhibitors in hepatocellular carcinoma through activating Hippo pathway
Deqiang Kong et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)
Molecular mechanisms underlying chemopreventive potential of butein: Current trends and future perspectives
Hardeep Singh Tuli et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2021)
Phosphodiesterase Type-5 Inhibitor Tadalafil Modulates Steroid Hormones Signaling in a Prostate Cancer Cell Line
Viviana M. Bimonte et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Protective and therapeutic effects of sildenafil and tadalafil on aflatoxin B1-induced hepatocellular carcinoma
Saurabh K. Chhonker et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)
The breast cancer drug market
Paul Wilcock et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Cyclic GMP in Liver Cirrhosis-Role in Pathophysiology of Portal Hypertension and Therapeutic Implications
Wolfgang Kreisel et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Hallmarks of cancer-the new testament
Sasi S. Senga et al.
OPEN BIOLOGY (2021)
New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil
Marian Cruz-Burgos et al.
FRONTIERS IN ONCOLOGY (2021)
Sildenafil prevents HDACi-induced Epstein-Barr virus reactivation through the PKG pathway in NK/T cell lymphoma; potential implications for HDACi-mediated fatal complications
Joo Hyun Kim et al.
ANTIVIRAL RESEARCH (2021)
PDE9 Inhibitor PF-04447943 Attenuates DSS-Induced Colitis by Suppressing Oxidative Stress, Inflammation, and Regulating T-Cell Polarization
Mohammad Nasiruddin Rana et al.
FRONTIERS IN PHARMACOLOGY (2021)
Unfolding New Roles for Guanine-Based Purines and Their Metabolizing Enzymes in Cancer and Aging Disorders
P. Di Iorio et al.
FRONTIERS IN PHARMACOLOGY (2021)
The PDE5 inhibitor udenafil ameliorates nonalcoholic fatty liver disease by improving mitochondrial function
Hea Min Yu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Tadalafil Reverses the Effect of Three-Dimensional Cell Culture System on Stem Cell Features in A549 and SK-MES-1
Mengqing Li et al.
DNA AND CELL BIOLOGY (2021)
Sildenafil Citrate and Risk of Biochemical Recurrence in Prostate Cancer Patients Treated With Radiation Therapy: Post-Hoc Analysis of a Randomized Controlled Trial
Justin M. Haseltine et al.
JOURNAL OF SEXUAL MEDICINE (2021)
Phosphodiesterase 7(PDE7): A unique drug target for central nervous system diseases
Ying Chen et al.
NEUROPHARMACOLOGY (2021)
The Potential Role of Sildenafil in Cancer Management through EPR Augmentation
Mohamed Haider et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
cGMP Signaling and Modulation in Heart Failure
Robert M. Blanton
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2020)
Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
Yiran Liang et al.
SEMINARS IN CANCER BIOLOGY (2020)
Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease
Nikolaos Tzoumas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Sildenafil triggers tumor lethality through altered expression of HSP90 and degradation of PKD2
Lu Chen et al.
CARCINOGENESIS (2020)
PDE-7 Inhibitor BRL-50481 Reduces Neurodegeneration and Long-Term Memory Deficits in Mice Following Sevoflurane Exposure
Yingle Chen et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Compartmentalization of adenosine metabolism in cancer cells and its modulation during acute hypoxia
Karolina Losenkova et al.
JOURNAL OF CELL SCIENCE (2020)
Discovery of Novel Agents on Spindle Assembly Checkpoint to Sensitize Vinorelbine-Induced Mitotic Cell Death against Human Non-Small Cell Lung Cancers
Ya-Ching Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling
Jui-Ling Hsu et al.
FRONTIERS IN ONCOLOGY (2020)
Sildenafil Potentiates the Therapeutic Efficacy of Docetaxel in Advanced Prostate Cancer by Stimulating NO-cGMP Signaling
Sakthivel Muniyan et al.
CLINICAL CANCER RESEARCH (2020)
Role of regulatory miRNAs of the Wnt/ β-catenin signaling pathway in tumorigenesis of breast cancer
Farzad Rahmani et al.
GENE (2020)
Phosphodiesterase-5 inhibitors use and risk for mortality and metastases among male patients with colorectal cancer
Wuqing Huang et al.
NATURE COMMUNICATIONS (2020)
Sildenafil enhances cisplatin-induced apoptosis in human breast adenocarcinoma cells
Fariba Hassanvand et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2020)
Nucleotide de novo synthesis increases breast cancer stemness and metastasis via cGMP-PKG-MAPK signaling pathway
Yajing Lv et al.
PLOS BIOLOGY (2020)
Elucidation of cGMP-dependent induction of mitochondrial biogenesis through PKG and p38 MAPK in the kidney
Pallavi Bhargava et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2020)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Therapeutic targeting of 3′,5′-cyclic nucleotide phosphodiesterases: inhibition and beyond
George S. Baillie et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma
Su Jong Yu et al.
JOURNAL OF HEPATOLOGY (2019)
Sildenafil citrate improves the delivery and anticancer activity of doxorubicin formulations in a mouse model of breast cancer
Khaled Greish et al.
JOURNAL OF DRUG TARGETING (2018)
Stimulators and activators of soluble guanylate cyclase for urogenital disorders
Fabiola Z. Monica et al.
NATURE REVIEWS UROLOGY (2018)
PDE5 inhibitors - pharmacology and clinical applications 20 years after sildenafil discovery
K-E Andersson
BRITISH JOURNAL OF PHARMACOLOGY (2018)
PDE5 inhibition eliminates cancer stem cells via induction of PKA signaling
Saskia Klutzny et al.
CELL DEATH & DISEASE (2018)
Phosphodiesterase-5 inhibitors for colon cancer chemoprevention
Bianca N. Islam et al.
AGING-US (2018)
Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents
Pan Pantziarka et al.
ECANCERMEDICALSCIENCE (2018)
Phosphodiesterase type 5 inhibitors and risk of melanoma: A meta-analysis
Huilin Tang et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Curcumin interacts with sildenafil to kill GI tumor cells via endoplasmic reticulum stress and reactive oxygen/nitrogen species
Jane L. Roberts et al.
ONCOTARGET (2017)
Phosphodiesterase type 5 and cancers: progress and challenges
Ines Barone et al.
ONCOTARGET (2017)
[pemetrexed plus sildenafil], via autophagy-dependent HDAC downregulation, enhances the immunotherapy response of NSCLC cells
Laurence Booth et al.
CANCER BIOLOGY & THERAPY (2017)
mTORC1 Couples Nucleotide Synthesis to Nucleotide Demand Resulting in a Targetable Metabolic Vulnerability
Alexander J. Valvezan et al.
CANCER CELL (2017)
Sildenafil Suppresses Inflammation-Driven Colorectal Cancer in Mice
Bianca N. Islam et al.
CANCER PREVENTION RESEARCH (2017)
Expression and Function of Phosphodiesterase Type 5 in Human Breast Cancer Cell Lines and Tissues: Implications for Targeted Therapy
Stefania Catalano et al.
CLINICAL CANCER RESEARCH (2016)
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)
Christopher J. Edwards et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
The cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinoma
Traci R. Tuttle et al.
CANCER LETTERS (2016)
New Therapeutic Applications of Phosphodiesterase 5 Inhibitors (PDE5-Is)
Giovanni Ribaudo et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Sildenafil potentiates the antitumor activity of cisplatin by induction of apoptosis and inhibition of proliferation and angiogenesis
Mona El-Naa et al.
Drug Design Development and Therapy (2016)
Celecoxib enhances [sorafenib plus sildenafil] lethality in cancer cells and reverts platinum chemotherapy resistance
Timothy Webb et al.
CANCER BIOLOGY & THERAPY (2015)
PDE5 Inhibitors Enhance Celecoxib Killing in Multiple Tumor Types
Laurence Booth et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Vardenafil, a clinically available phosphodiesterase inhibitor, potentiates the killing effect of EGCG on CLL cells
Motofumi Kumazoe et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Phosphodiesterase type 5 inhibitor Tadalafil increases Rituximab treatment efficacy in a mouse brain lymphoma model
Rong Wang et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Structures of soluble guanylate cyclase: implications for regulatory mechanisms and drug development
Opher Gileadi
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
Calcium influx pathways in breast cancer: opportunities for pharmacological intervention
I. Azimi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Breast Cancer Statistics, 2013
Carol DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Protein and Nucleotide Biosynthesis Are Coupled by a Single Rate-Limiting Enzyme, PRPS2, to Drive Cancer
John T. Cunningham et al.
CELL (2014)
Identification and validation of genes with expression patterns inverse to multiple metastasis suppressor genes in breast cancer cell lines
Natascia Marino et al.
CLINICAL & EXPERIMENTAL METASTASIS (2014)
Advances in targeting cyclic nucleotide phosphodiesterases
Donald H. Maurice et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Co-delivery of Sildenafil (Viagra®) and Crizotinib for Synergistic and Improved Anti-tumoral Therapy
Joao G. Marques et al.
PHARMACEUTICAL RESEARCH (2014)
Riociguat for pulmonary hypertension
John E. Cannon et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2014)
The Role of Cyclic Nucleotide Signaling Pathways in Cancer: Targets for Prevention and Treatment
Alexandra M. Fajardo et al.
CANCERS (2014)
Cyclic Nucleotide Compartmentalization: Contributions of Phosphodiesterases and ATP-Binding Cassette Transporters
Satish Cheepala et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Cell cycle regulation of purine synthesis by phosphoribosyl pyrophosphate and inorganic phosphate
Alla Fridman et al.
BIOCHEMICAL JOURNAL (2013)
Mitochondrial-associated nitric oxide synthase activity inhibits cytochrome c oxidase: Implications for breast Cancer
Suvajit Sen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Inhibition of phosphodiestrase 9 induces cGMP accumulation and apoptosis in human breast cancer cell lines, MCF-7 and MDA-MB-468
R. Saravani et al.
CELL PROLIFERATION (2012)
Type II cGMP-dependent protein kinase inhibits EGF-induced MAPK/JNK signal transduction in breast cancer cells
Ting Lan et al.
ONCOLOGY REPORTS (2012)
Inhibition of PDE5 by Sulindac Sulfide Selectively Induces Apoptosis and Attenuates Oncogenic Wnt/β-Catenin-Mediated Transcription in Human Breast Tumor Cells
Heather N. Tinsley et al.
CANCER PREVENTION RESEARCH (2011)
Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines
Faranak Fallahian et al.
FEBS JOURNAL (2011)
Nitric Oxide, Cytochrome C Oxidase, and the Cellular Response to Hypoxia
Cormac T. Taylor et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells
Xu Di et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
cGMP-dependent protein kinases as potential targets for colon cancer prevention and treatment
Darren D. Browning et al.
FUTURE MEDICINAL CHEMISTRY (2010)
Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation
Kalpana Mujoo et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2010)
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
Sharron H. Francis et al.
PHARMACOLOGICAL REVIEWS (2010)
Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction
Anindita Das et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Nitric oxide and cancer
Jordi Muntane et al.
WORLD JOURNAL OF HEPATOLOGY (2010)
Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G
Heather N. Tinsley et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
Jack Cuzick et al.
LANCET ONCOLOGY (2009)
PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model
Keith L. Black et al.
BRAIN RESEARCH (2008)
ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor α expression in postmenopausal breast tumors and overexpressed in tamoxifen-resistant breast cancer cells
Mylene Honorat et al.
ENDOCRINE-RELATED CANCER (2008)
Anti-Inflammatory, Antiproliferative, and Cytoprotective Activity of NO Chimera Nitrates of Use in Cancer Chemoprevention
Ghenet K. Hagos et al.
MOLECULAR PHARMACOLOGY (2008)
NO-donating NSAIDs and cancer: An overview with a note on whether NO is required for their action
Basil Rigas et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2008)
NSAIDs and breast cancer recurrence in a prospective cohort study
Marilyn L. Kwan et al.
CANCER CAUSES & CONTROL (2007)
The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy
N. Mehrotra et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2007)
Overview of PDEs and their regulation
Kenji Omori et al.
CIRCULATION RESEARCH (2007)
Capturing cyclic nucleotides in action: snapshots from crystallographic studies
Holger Rehmann et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells
M Fraser et al.
ONCOGENE (2006)
Tadalafil pharmacokinetics in healthy subjects
ST Forgue et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour
GMK Tse et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Activation of protein kinase G is sufficient to induce apoptosis and inhibit cell migration in colon cancer cells
A Deguchi et al.
CANCER RESEARCH (2004)
Cyclic GMP-dependent protein kinases and the cardiovascular system
R Feil et al.
CIRCULATION RESEARCH (2003)
Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase
LC Jadeski et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Regulation of nitric oxide-sensitive guanylyl cyclase
A Friebe et al.
CIRCULATION RESEARCH (2003)
Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells
PR Wielinga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Basic fibroblast growth factor activates endothelial nitric-oxide synthase in CHO-K1 cells via the activation of ceramide synthesis
T Florio et al.
MOLECULAR PHARMACOLOGY (2003)
Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells
M Sarfati et al.
BLOOD (2003)
The type IV phosphodiesterase inhibitor rolipram induces expression of the cell cycle inhibitors p21Cip1 and p27Kip1, resulting in growth inhibition, increased differentiation, and subsequent apoptosis of malignant A-172 glioma cells
TC Chen et al.
CANCER BIOLOGY & THERAPY (2002)
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer
AJ Dannenberg et al.
LANCET ONCOLOGY (2001)
Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice
CH Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Xenobiotic-metabolizing cytochromes P450 convert prostaglandin endoperoxide to hydroxyheptadecatrienoic acid and the mutagen, malondialdehyde
JP Plastaras et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
